

NHL highlights at ASH 2022: updates in MCL, the role of transplantation, and novel bispecific antibodies
Feb 2, 2023
Experts Michael Dickinson and Tycel Phillips discuss updates in non-Hodgkin lymphoma at ASH 2022, including the TRIANGLE trial, the changing role of transplantation, and novel immunotherapies in the field.
Chapters
Transcript
Episode notes
1 2 3 4
Introduction
00:00 • 3min
Updates on BTK inhibitors, transplantation, and novel therapies in MCL
03:10 • 2min
Updates on CAR-T patients and the use of bi-specific agents in lymphomas
05:00 • 4min
Long-term follow-up and sequencing of CAR-T treatments in patients with aggressive B-cell lymphomas
08:43 • 2min